This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Dunger, D. B. Articles by Wolfsdorf, J. I. Search for Related Content PubMed PubMed Citation Articles by Dunger, D. B. Articles by Wolfsdorf, J. I. Related Collections Endocrinology Social Bookmarking                         What's this?

European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents

David B. Dunger, MD^*,, Mark A. Sperling, MD^,, Carlo L. Acerini, MD^*, Desmond J. Bohn, MD, Denis Daneman, MD^,, Thomas P.A. Danne, MD^*,, Nicole S. Glaser, MD, Ragnar Hanas, MD^*,, Raymond L. Hintz, MD, Lynne L. Levitsky, MD, Martin O. Savage, MD^*,, Robert C. Tasker, MD^* and Joseph I. Wolfsdorf, MD

^* European Society for Paediatric Endocrinology, West Smithfield, London, United Kingdom
Lawson Wilkins Pediatric Endocrine Society, Stanford, CA
International Society for Paediatric and Adolescent Diabetes, Leicester, United Kingdom

Abbreviations: DKA, diabetic ketoacidosis • TIDM, type 1 diabetes mellitus • LWPES, Lawson Wilkins Pediatric Endocrine Society • ESPE, European Society for Paediatric Endocrinology • ß-OHB, ß-hydroxybutyrate • CNS, central nervous system • IV, intravenous • ICP, intracranial pressure • ECF, extracellular fluid • ICF, intracellular fluid • GFR, glomerular filtration rate

The first 300 words of the full text of this article appear below.

	INTRODUCTION

 
Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes mellitus (TIDM). Mortality is predominantly related to the occurrence of cerebral edema; only a minority of deaths in DKA are attributed to other causes. Cerebral edema occurs in 0.3% to 1% of all episodes of DKA, and its etiology, pathophysiology, and ideal method of treatment are poorly understood. There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA to be managed. There is agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes.

To explore these issues, the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the European Society for Pediatric Endocrinology (ESPE) convened a panel^|| of expert physicians for a consensus conference. The meeting was chaired by Mark A. Sperling, MD, representing LWPES, and David B. Dunger, MD, representing ESPE. The Consensus statement was developed with close partnership between the ESPE and LWPES and the International Society for Pediatric and Adolescent Diabetes, all 3 organizations being represented by members who participated in the writing process. The statement also was endorsed by related organizations; the Juvenile Diabetes Research Foundation International, the World Federation of Pediatric Intensive and Critical Care Societies, the European Society for Pediatric Critical Care, the European Society of Pediatric and Neonatal Intensive Care, and the Australian Pediatric Endocrine Group were represented by invited participants.

Each of the major topics had a presenter and recorder, responsible for review of the literature and providing evidence-based recommendations according to criteria used by the American Diabetes Association (see Appendix; levels of evidence are indicated in capital letters, in parentheses).¹ Type 2 diabetes was not considered. All participants contributed significantly to . . . [Full Text of this Article]

Address correspondence to David B. Dunger, Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Level 8, Box 116, Cambridge CB2 2QQ, United Kingdom. E-mail: dbd25@cam.ac.uk; or Mark A. Sperling, Department of Pediatrics/Endocrinology, Children’s Hospital of Pittsburgh, 3705 Fifth Ave, Pittsburgh, PA 15213. E-mail: masp@pitt.edu

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. M. Triolo, H. P. Chase, J. M. Barker, and the DPT-1 Study Group Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial-Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset Diabetes Care, May 1, 2009; 32(5): 769 - 773. [Abstract] [Full Text] [PDF]

				S Muralidharan, V Datta, and V Palanivel Recurrent diabetic ketoacidosis in an adolescent Arch. Dis. Child., May 1, 2009; 94(5): 365 - 365. [Full Text] [PDF]

				N. Kuppermann, J. Park, K. Glatter, J. P. Marcin, and N. S. Glaser Prolonged QT Interval Corrected for Heart Rate During Diabetic Ketoacidosis in Children Arch Pediatr Adolesc Med, June 1, 2008; 162(6): 544 - 549. [Abstract] [Full Text] [PDF]

				A. Hekkala, M. Knip, and R. Veijola Ketoacidosis at Diagnosis of Type 1 Diabetes in Children in Northern Finland: Temporal changes over 20 years Diabetes Care, April 1, 2007; 30(4): 861 - 866. [Abstract] [Full Text] [PDF]

				A.P.C.P. Carlotti, D. Bohn, N. Jankiewicz, K.S. Kamel, M.R. Davids, and M.L. Halperin A hyperglycaemic hyperosmolar state in a young child: diagnostic insights from a quantitative analysis QJM, February 1, 2007; 100(2): 125 - 137. [Abstract] [Full Text] [PDF]

				J Kratzsch, I Knerr, A Galler, T Kapellen, K Raile, A Korner, J Thiery, J Dotsch, and W Kiess Metabolic decompensation in children with type 1 diabetes mellitus associated with increased serum levels of the soluble leptin receptor. Eur. J. Endocrinol., October 1, 2006; 155(4): 609 - 614. [Abstract] [Full Text] [PDF]

				V. R. Bhardwaj, N. Metcalfe, E. Innes, E. Harrison, and D. Jenkins Recurrent diabetic ketoacidosis after changing pen devices for insulin injection. BMJ, May 27, 2006; 332(7552): 1259 - 1260. [Full Text] [PDF]

				T. Della Manna, L. Steinmetz, P. R. Campos, S. C.L. Farhat, C. Schvartsman, H. Kuperman, N. Setian, and D. Damiani Subcutaneous Use of a Fast-Acting Insulin Analog: An alternative treatment for pediatric patients with diabetic ketoacidosis Diabetes Care, August 1, 2005; 28(8): 1856 - 1861. [Abstract] [Full Text] [PDF]

				J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. Grey, B. Anderson, L. A. Holzmeister, et al. Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association Diabetes Care, January 1, 2005; 28(1): 186 - 212. [Full Text] [PDF]

				A. B. Muir, R. G. Quisling, M. C.K. Yang, and A. L. Rosenbloom Cerebral Edema in Childhood Diabetic Ketoacidosis: Natural history, radiographic findings, and early identification Diabetes Care, July 1, 2004; 27(7): 1541 - 1546. [Abstract] [Full Text] [PDF]

				S. L. Bratton The Consensus Conference on Diabetic Ketoacidosis AAP Grand Rounds, May 1, 2004; 11(5): 56 - 57. [Full Text] [PDF]